Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
TSE:4506
Price:
516
JPY
-5.49%
Market Closed
Market Cap:
205.3B
JPY
Balance Sheet
Balance Sheet Decomposition
Sumitomo Pharma Co Ltd
Sumitomo Pharma Co Ltd
| Current Assets | 333.7B |
| Cash & Short-Term Investments | 102B |
| Receivables | 97.3B |
| Other Current Assets | 134.4B |
| Non-Current Assets | 518.4B |
| Long-Term Investments | 38.2B |
| PP&E | 52.6B |
| Intangibles | 403.3B |
| Other Non-Current Assets | 24.4B |
Balance Sheet
Sumitomo Pharma Co Ltd
Sumitomo Pharma Co Ltd
Currency: JPY
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
30 553
|
54 922
|
105 603
|
147 775
|
137 296
|
101 708
|
193 698
|
202 984
|
143 478
|
29 047
|
|
| Cash Equivalents |
30 553
|
54 922
|
105 603
|
147 775
|
137 296
|
101 708
|
193 698
|
202 984
|
143 478
|
29 047
|
|
| Short-Term Investments |
111 293
|
81 039
|
17 494
|
22 066
|
43 750
|
28 717
|
29 480
|
35 596
|
20 174
|
7 085
|
|
| Total Receivables |
151 999
|
155 587
|
118 966
|
113 401
|
119 243
|
140 368
|
136 060
|
151 500
|
98 630
|
97 239
|
|
| Accounts Receivables |
102 947
|
107 161
|
110 700
|
110 582
|
116 059
|
129 368
|
128 569
|
141 020
|
86 405
|
68 818
|
|
| Other Receivables |
49 052
|
48 426
|
8 266
|
2 819
|
3 184
|
11 000
|
7 491
|
10 480
|
12 225
|
28 421
|
|
| Inventory |
62 387
|
59 587
|
60 286
|
60 169
|
66 889
|
79 368
|
92 215
|
99 021
|
94 405
|
115 350
|
|
| Other Current Assets |
45 467
|
70 449
|
5 211
|
5 170
|
6 090
|
13 929
|
8 342
|
10 420
|
25 173
|
20 848
|
|
| Total Current Assets |
401 699
|
421 584
|
307 560
|
348 581
|
373 268
|
364 090
|
459 795
|
499 521
|
381 860
|
269 569
|
|
| PP&E Net |
65 160
|
61 824
|
61 121
|
58 204
|
59 485
|
65 748
|
64 966
|
64 091
|
58 909
|
57 895
|
|
| PP&E Gross |
65 160
|
61 824
|
61 121
|
58 204
|
59 485
|
65 748
|
64 966
|
64 091
|
58 909
|
57 895
|
|
| Accumulated Depreciation |
148 272
|
154 453
|
159 828
|
161 841
|
157 542
|
129 214
|
122 819
|
132 888
|
130 474
|
129 724
|
|
| Intangible Assets |
85 788
|
79 630
|
197 114
|
189 681
|
171 390
|
421 029
|
383 406
|
398 692
|
329 314
|
195 652
|
|
| Goodwill |
88 075
|
76 950
|
100 194
|
95 097
|
99 348
|
173 464
|
176 492
|
195 144
|
209 415
|
199 783
|
|
| Note Receivable |
0
|
0
|
0
|
2 453
|
2 562
|
0
|
6 726
|
5 538
|
6 042
|
6 846
|
|
| Long-Term Investments |
58 193
|
60 432
|
52 681
|
70 993
|
74 668
|
200 923
|
193 035
|
115 844
|
134 007
|
161 711
|
|
| Other Long-Term Assets |
12 668
|
7 295
|
60 402
|
44 675
|
53 996
|
31 280
|
23 707
|
29 177
|
15 195
|
16 050
|
|
| Other Assets |
88 075
|
76 950
|
100 194
|
95 097
|
99 348
|
173 464
|
176 492
|
195 144
|
209 415
|
199 783
|
|
| Total Assets |
711 583
N/A
|
707 715
-1%
|
779 072
+10%
|
809 684
+4%
|
834 717
+3%
|
1 256 534
+51%
|
1 308 127
+4%
|
1 308 007
0%
|
1 134 742
-13%
|
907 506
-20%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
12 492
|
12 153
|
14 514
|
17 512
|
15 498
|
25 640
|
26 076
|
22 455
|
13 403
|
20 765
|
|
| Accrued Liabilities |
0
|
10 809
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
1 010
|
40 000
|
3 500
|
0
|
270 000
|
5 000
|
5 025
|
90 588
|
174 588
|
|
| Current Portion of Long-Term Debt |
36 522
|
22 000
|
18 000
|
12 960
|
3 697
|
9 097
|
11 019
|
25 832
|
4 660
|
114 710
|
|
| Other Current Liabilities |
98 413
|
133 750
|
159 619
|
176 276
|
178 979
|
191 761
|
236 052
|
225 061
|
264 043
|
205 411
|
|
| Total Current Liabilities |
156 843
|
179 722
|
232 133
|
210 248
|
198 174
|
496 498
|
278 147
|
278 373
|
372 694
|
515 474
|
|
| Long-Term Debt |
50 000
|
28 000
|
10 000
|
30 940
|
29 286
|
37 745
|
275 526
|
254 510
|
251 124
|
138 566
|
|
| Deferred Income Tax |
15 704
|
16 209
|
72
|
95
|
0
|
26 768
|
28 424
|
26 550
|
36 505
|
38 211
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
103 190
|
67 608
|
65 681
|
33
|
73
|
|
| Other Liabilities |
36 365
|
37 312
|
124 599
|
115 678
|
109 119
|
59 663
|
77 852
|
75 005
|
67 637
|
59 119
|
|
| Total Liabilities |
260 562
N/A
|
261 243
+0%
|
366 804
+40%
|
356 961
-3%
|
336 579
-6%
|
723 864
+115%
|
727 557
+1%
|
700 119
-4%
|
727 993
+4%
|
751 443
+3%
|
|
| Equity | |||||||||||
| Common Stock |
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
|
| Retained Earnings |
326 686
|
341 401
|
357 769
|
396 037
|
431 799
|
457 330
|
508 677
|
514 210
|
280 999
|
22 665
|
|
| Additional Paid In Capital |
15 860
|
15 860
|
15 860
|
15 860
|
15 861
|
17 837
|
15 855
|
16 725
|
0
|
0
|
|
| Unrealized Security Profit/Loss |
17 247
|
0
|
0
|
31 735
|
32 611
|
46 118
|
38 575
|
23 838
|
39 260
|
64 526
|
|
| Treasury Stock |
660
|
0
|
667
|
669
|
674
|
677
|
679
|
681
|
682
|
682
|
|
| Other Equity |
63 636
|
42 181
|
16 906
|
12 640
|
3 859
|
10 338
|
4 258
|
31 396
|
64 772
|
92 484
|
|
| Total Equity |
451 021
N/A
|
446 472
-1%
|
412 268
-8%
|
452 723
+10%
|
498 138
+10%
|
532 670
+7%
|
580 570
+9%
|
607 888
+5%
|
406 749
-33%
|
156 063
-62%
|
|
| Total Liabilities & Equity |
711 583
N/A
|
707 715
-1%
|
779 072
+10%
|
809 684
+4%
|
834 717
+3%
|
1 256 534
+51%
|
1 308 127
+4%
|
1 308 007
0%
|
1 134 742
-13%
|
907 506
-20%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
397
|
397
|
397
|
397
|
397
|
397
|
397
|
397
|
397
|
397
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
